Biologics Global Market Opportunities And Strategies To 2021

Published - July 2018| Code - TBR004A| Affiliate - TBRC (Publisher)

Report Highlights

Including: Monoclonal Antibodies, Therapeutic Proteins, Vaccines

Covering: Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squibb, Pfizer Inc., Eli Lilly and Company, F. Hoffmann- La Roche, Merck & Co., GlaxoSmithKline, Sanofi

The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, vaccines, and monoclonal antibodies. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 10 working days of order.

Description

Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biologics market report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • A comparison of the biologics market with macro-economic factors and industry metrics is also covered in the report.
  • PESTLE Analysis covers the political, economic, social, technological, legal and environmental factors affecting the biologics market.
  • Market segmentations break down market into sub markets, including Monoclonal Antibodies, Therapeutic Proteins, Vaccines
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The report also covers key mergers and acquisitions in the biologics market. Key financial deals which have shaped the market in recent years are identified.

Scope

Markets covered: Monoclonal Antibodies, Therapeutic Proteins, Vaccines
Companies mentioned: Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squibb, Pfizer Inc., Eli Lilly and Company, F. Hoffmann- La Roche, Merck & Co., GlaxoSmithKline, Sanofi
Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, population, GDP
Data segmentations: Country historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table Table60 : Russia Biologics Market, Historic Market Size, 2017-2021, $ Billion
  • Table Table59 : Russia Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table Table54 : Spain Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table Table51 : Italy Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table Table50 : Italy Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table Table48 : France Biologics Market, Historic Market Size, 2017-2021, $ Billion
  • Table Table47 : France Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table Table45 : Germany Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table Table44 : Germany Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table Table42 : UK Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 1 : Global Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 2 : Global Biologics Market, Forecast Market Size, 2017 – 2021, $ Billion
  • Table 3 : Global Biologics Market, Split By Segments, 2017, $ Billion
  • Table 4 : Global Biologics Market, Historic and Forecast Growth Rates, Split By Segment, 2013 – 2021
  • Table 5 : Healthcare Market Segmentation, By Region, 2017
  • Table 6 : Healthcare Market Segmentation, By Country, 2017
  • Table 7 : Global Monoclonal Antibodies Market, 2017, By Source
  • Table 8 : Global Monoclonal Antibodies Market, 2017, By Therapeutic Area
  • Table 9 : Global Therapeutic Proteins Market Segmentation, 2017, By Type
  • Table 10 : Global Therapeutic Proteins Market Segmentation, 2017, By Therapeutic Area
  • Table 11 : Global Vaccines Market, 2017, By End User
  • Table 12 : Global Vaccines Market, 2017, By Therapeutic Area
  • Table 13 : Biologics Market, Split By Region, 2017, $ Billion
  • Table 14 : Biologics Market, Historic And Forecast Growth Rates, Split By Region, 2013-2021
  • Table 15 : Biologics Market, Split By Country, 2017, $ Billion
  • Table 16 : Biologics Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
  • Table 17 : Biosimilar And Biologic Drugs Sales Proportion, 2017, By Country (Value)
  • Table 18 : Global Biologics Under Development, 2017 By Therapeutic Area (Volume)
  • Table 19 : New Biologics Approved, 2017
  • Table 20 : Number Of General Practitioners 2016, By Country
  • Table 21 : Average Revenue Per General Practitioners 2016, By Country, $ Thousands
  • Table 22 : Asia Pacific Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 23 : Asia Pacific Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 24 : Asia Pacific Biologics Market, Split By Segments, 2017, $ Billion
  • Table 25 : Global Biologics Market, 2017, International Collaborations In Innovative Biologics
  • Table 26 : China Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 27 : China Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 28 : China Biologics Market, Split By Segments, 2017, $ Billion
  • Table 29 : India Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 30 : India Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 31 : India Biologics Market, Split By Segments, 2017, $ Billion
  • Table 32 : Japan Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 33 : Japan Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 34 : Japan Biologics Market, Split By Segments, 2017, $ Billion
  • Table 35 : Australia Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 36 : Australia Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 37 : Australia Biologics Market, Split By Segments, 2017, $ Billion
  • Table 38 : Western Europe Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 39 : Western Europe Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 40 : Western Europe Biologics Market, Split By Segments, 2017, $ Billion
  • Table 41 : UK Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 43 : UK Biologics Market, Split By Segments, 2017, $ Billion
  • Table 46 : Germany Biologics Market, Split By Segments, 2017, $ Billion
  • Table 49 : France Biologics Market, Split By Segments, 2017, $ Billion
  • Table 52 : Italy Biologics Market, Split By Segments, 2017, $ Billion
  • Table 53 : Spain Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 55 : Spain Biologics Market, Split By Segments, 2017, $ Billion
  • Table 56 : Eastern Europe Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 57 : Eastern Europe Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 58 : Eastern Europe Biologics Market, Split By Segments, 2017, $ Billion
  • Table 61 : Russia Biologics Market, Split By Segments, 2017, $ Billion
  • Table 62 : North America Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 63 : North America Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 64 : North America Biologics Market, Split By Segments, 2017, $ Billion
  • Table 65 : USA Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 66 : USA Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 67 : USA Biologics Market, Split By Segments, 2017, $ Billion
  • Table 68 : South America Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 69 : South America Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 70 : South America Biologics Market, Split By Segments, 2017, $ Billion
  • Table 71 : Brazil Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 72 : Brazil Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 73 : Brazil Biologics Market, Split By Segments, 2017, $ Billion
  • Table 74 : Middle East Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 75 : Middle East Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 76 : Middle East Biologics Market, Split By Segments, 2017, $ Billion
  • Table 77 : Africa Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Table 78 : Africa Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Table 79 : Africa Biologics Market, Split By Segments, 2017, $ Billion
  • Table 80 : Global Biologics Market, Key Competitor Market Shares, 2017, Percentage (%)
  • Table 81 : Global Biologics Market, Market Data Sources
  • Table 82 : Respondents Profile
  • Figure 1 : Global Biologics Market Value Chain
  • Figure 2 : Global Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 3 : Global Biologics Market, Forecast Market Size, 2017 – 2021, $ Billion
  • Figure 4 : Global Biologics Market, 2017, PESTLE Analysis
  • Figure 5 : Global Biologics Market, Split By Segments, 2017, $ Billion
  • Figure 6 : Healthcare Market Segmentation, By Region, 2017
  • Figure 7 : Healthcare Market Segmentation, By Country, 2017
  • Figure 8 : Global Monoclonal Antibodies Market, 2017, By Source
  • Figure 9 : Global Monoclonal Antibodies Market, 2017, By Therapeutic Area
  • Figure 10 : Global Therapeutic Proteins Market Segmentation, 2017, By Type
  • Figure 11 : Global Therapeutic Proteins Market Segmentation, 2017, By Therapeutic Area
  • Figure 12 : Global Vaccines Market, 2017, By End User
  • Figure 13 : Global Vaccines Market, 2017, By Therapeutic Area
  • Figure 14 : Biologics Market, Split By Region, 2017, $ Billion
  • Figure 15 : Biologics Market, Historic And Forecast Growth Rates, Split By Region, 2013-2021
  • Figure 16 : Biologics Market, Split By Country, 2017, $ Billion
  • Figure 17 : Biologics Market, Historic And Forecast Growth Rates, Split By Country, 2013-2021
  • Figure 18 : Global Biologics Market Value, Market Size as A Percentage of Global GDP, 2013 – 2021, $ Billion
  • Figure 19 : Global Biologics Market, Per Capita Average Biologics Expenditure, 2013 – 2021, ($)
  • Figure 20 : Biologics Market Size As A Percentage Of GDP, 2013, 2017 and 2021
  • Figure 21 : Biologics Market, Per Capita Average Biologics Expenditure, By Country, 2013, 2017 And 2021, ($)
  • Figure 22 : Biologics And Biosimilars Drugs Sales Proportion, 2017, By Country (Value)
  • Figure 23 : Global Biologics Under Development, 2017, By Therapeutic Area (Volume)
  • Figure 24 : New Biologics Approved, 2017
  • Figure 25 : Number Of General Practitioners 2016, By Country
  • Figure 26 : Average Biologics Revenue Per General Practitioner 2016, By Country, $ Thousands
  • Figure 27 : Asia Pacific Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 28 : Asia Pacific Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 29 : Asia Pacific Biologics Market, 2017, By Segment, %
  • Figure 30 : China Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 31 :
  • Figure 32 : China Biologics Market, 2017, By Segment, %
  • Figure 33 : India Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 34 : India Biologics Market, forecast Market Size, 2017-2021, $ Billion
  • Figure 35 : India Biologics Market, 2017, By Segment, %
  • Figure 36 : Japan Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 37 : Japan Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 38 : Japan Biologics Market, 2017, By Segment, %
  • Figure 39 : Australia Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 40 : Australia Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 41 : Australia Biologics Market, 2017, By Segment, %
  • Figure 42 : Western Europe Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 43 : Western Europe Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 44 : Western Europe Biologics Market, 2017, By Segment, %
  • Figure 45 : UK Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 46 : UK Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 47 : UK Biologics Market, 2017, By Segment, %
  • Figure 48 : Germany Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 49 : Germany Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 50 : Germany Biologics Market, 2017, By Segment, %
  • Figure 51 : France Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 52 : France Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 53 : France Biologics Market, 2017, By Segment, %
  • Figure 54 : Italy Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 55 : Italy Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 56 : Italy Biologics Market, 2017, By Segment, %
  • Figure 57 : Spain Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 58 : Spain Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 59 : Spain Biologics Market, 2017, By Segment, %
  • Figure 60 : Eastern Europe Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 61 : Eastern Europe Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 62 : Eastern Europe Biologics Market, 2017, By Segment, %
  • Figure 63 : Russia Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 64 : Russia Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 65 : Russia Biologics Market, 2017, By Segment, %
  • Figure 66 : North America Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 67 : North America Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 68 : North America Biologics Market, 2017, By Segment, %
  • Figure 69 : USA Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 70 : USA Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 71 : USA Biologics Market, 2017, By Segment, %
  • Figure 72 : South America Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 73 : South America Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 74 : South America Biologics Market, 2017, By Segment, %
  • Figure 75 : Brazil Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 76 : Brazil Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 77 : Brazil Biologics Market, 2017, By Segment, %
  • Figure 78 : Middle East Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 79 : Middle East Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 80 : Middle East Biologics Market, 2017, By Segment, %
  • Figure 81 : Africa Biologics Market, Historic Market Size, 2013-2017, $ Billion
  • Figure 82 : Africa Biologics Market, Forecast Market Size, 2017-2021, $ Billion
  • Figure 83 : Africa Biologics Market, 2017, By Segment, %
  • Figure 84 : Global Biologics Market, Key Competitor Market Shares, 2017, Percentage (%)

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report